Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 17 of 17 entries
View as:

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01501461 Org: User:
Start: 05/01/11 End: 06/30/17 Due: 06/30/18

Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01502501 Org: User:
Start: 05/31/11 End: 06/30/15 Due: 06/30/16

Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT02087397 Org: User:
Start: 03/31/14 End: 12/31/17 Due: 12/31/18

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Renal Failure

Phase: N/A Priority: Normal
NCT ID: NCT01453816 Org: User:
Start: 05/31/11 End: 06/30/15 Due: 06/30/16

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01453764 Org: User:
Start: 04/30/16 End: 04/30/19 Due: 04/30/20

Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections for the Treatment of Critical Limb Ischemia

Phase: N/A Priority: Normal
NCT ID: NCT02099500 Org: User:
Start: 03/31/14 End: 06/30/17 Due: 06/30/18

Study to Assess Safety & Effects of Autologous ADSCs During Recovery Phase of ST-Elevation MI Effects of Autologous ADSC Implantation During Subacute Recovery Phase of ST-Elevation Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT03272191 Org: User:
Start: 09/30/16 End: 12/31/18 Due: 12/31/19

Study to Assess the Safety and Effects of Autologous Adipose-Derived SVF Cells in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01453803 Org: User:
Start: 05/31/14 End: 12/31/17 Due: 12/31/18

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01453829 Org: User:
Start: 10/31/14 End: 06/30/15 Due: 06/30/16

Autologous Adipose-Derived Stromal Cells Delivered Intra-articularly in Patients With Osteoarthritis.

Phase: N/A Priority: Normal
NCT ID: NCT01739504 Org: User:
Start: 03/01/14 End: 04/01/17 Due: 04/01/18

Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT01974128 Org: User:
Start: 10/31/14 End: 01/31/17 Due: 01/31/18

Adipose Derived Stem Cell Therapy for Autism

Phase: N/A Priority: Normal
NCT ID: NCT01502488 Org: User:
Start: 10/31/16 End: 01/31/18 Due: 01/31/19

Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01502514 Org: User:
Start: 05/31/11 End: 06/30/15 Due: 06/30/16

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02912169 Org: User:
Start: 11/01/15 End: 11/15/17 Due: 11/15/18

Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Diffuse Lesions in the Brain

Phase: N/A Priority: Normal
NCT ID: NCT01453777 Org: User:
Start: 05/31/11 End: 06/30/15 Due: 06/30/16

Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01559051 Org: User:
Start: 03/31/14 End: 12/31/17 Due: 12/31/18

Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01453751 Org: User:
Start: 03/31/14 End: 12/31/17 Due: 12/31/18